세계의 중요 장기 지원 시스템 및 의료 바이오닉스 시장 규모 : 제품별, 최종 사용자별, 지역별, 범위 및 예측

Vital Organs Support Systems And Medical Bionics Market Size And Forecast

Vital Organs Support Systems And Medical Bionics Market size was valued at USD 46.43 Billion in 2024 and is projected to reach USD 96.66 Billion By 2031, growing at a CAGR of 9.60% from 2024 to 2031. This is brought on by a dearth of organ donors, an increase in organ transplant cases, a rise in the number of persons needing organ transplants due to hereditary or accidental disabilities, and a rise in the incidence of chronic diseases. The Global Vital Organs Support Systems And Medical Bionics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Vital Organs Support Systems And Medical Bionics Market Definition

The artificial organs that make up the Organ Support System are created to mimic natural human organ function and are used to replace missing or damaged organs as well as support already functioning organs. These synthetic organs connect to living tissues and take the place of missing human organs.

The study of mechanical systems that duplicate organisms or specific living organism parts is known as medical bionics. Artificial organ support systems and medical bionics have the advantages of lessening the dependence on human donors, reducing the risk of organ rejection, and providing a more affordable treatment option for a variety of disorders. These advantages are anticipated to assist the market for medical bionics and systems to support essential organs as they expand.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Vital Organs Support Systems And Medical Bionics Market Overview

In recent years, the global market for medical bionics and systems to support important organs has experienced significant expansion, and in the years to come, it is anticipated to continue to expand significantly both in terms of share and value. This is brought on by a dearth of organ donors, an increase in organ transplant cases, a rise in the number of persons needing organ transplants due to hereditary or accidental disabilities, and a rise in the incidence of chronic diseases. Additionally, throughout the forecast period, factors such as the continually growing elderly population, and advancements in product technologies are anticipated to boost the growth of the global market for medical bionics and vital organ support systems.

However, the market growth for medical bionics and vital organ support systems is anticipated to be constrained by the high cost of artificial devices and medical bionics as well as strict regulatory approval procedures. Moreover, in the coming years, favorable reimbursement policies, financial support from the public and private sectors, as well as favorable healthcare coverage schemes, will support the growth of the market for medical bionics and systems that support vital organs.

Global Vital Organs Support Systems And Medical Bionics Market Segmentation Analysis

The Global Vital Organs Support Systems And Medical Bionics Market is Segmented based on Product, End-User, And Geography.

Vital Organs Support Systems And Medical Bionics Market, By Product

• Vital Organs Support Systems
• Artificial Heart
• Artificial Kidney
• Artificial Liver
• Others
• Medical Bionics
• Cardiac Bionics
• Orthopedic Bionics
• Neural Bionics
• Others

Based on product, the market is segmented into vital organs support systems, and medical bionics. The vital organs support systems segment is segmented into artificial hearts, artificial livers, artificial kidneys, and others. The medical bionics market is classified into cardiac bionics, orthopedic bionics, neural bionics, and others. The vital organs support systems segment dominated the major market share of the vital organs support systems and medical bionics market. The growth of the segment is primarily attributed to a surge in patient acceptance that is poised to increase as more people become aware of medical bionics. Continuous advances in the fields of biomedical engineering and medical science are anticipated to increase the use rate of synthetic organs during the projected period.

Vital Organs Support Systems And Medical Bionics Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Others

Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. the hospital segment dominated the major market share of the vital organs support systems and medical bionics market. The availability of numerous support departments, including MRI suites and ICUs, is responsible for the segment's expansion. Additionally, hospitals have more staff on hand to deal with complications. When complications arise during an operation, patients are frequently transferred from an ambulatory surgery center to the closest hospital, which will speed up the growth of the hospital segment throughout the forecast period.

Vital Organs Support Systems And Medical Bionics Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin Ameria
• Middle East & Africa

Based on Geography, the Global Vital Organs Support Systems And Medical Bionics Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market for medical bionics and systems to support key organs is dominated mostly by North America. This can be attributed to the rising prevalence of artificial organs in emerging markets, the existence of numerous key players participating in this market, the presence of a large number of players working in this industry, as well as the potential growth of healthcare spending. Furthermore, because cadaveric organ donation is so uncommon, artificial organ transplants are probably going to become more typical. An increasing number of new product approvals linked to the best use of innovative transplants are predicted to fuel market expansion over the forecast period. The industry is positioned to be driven by significant private-sector expenditures.

• However, due to the rising prevalence of amputations from trauma and accidents, as well as brain injuries that cause visual and hearing loss, Asia-Pacific is predicted to have the fastest growth during the forecast period. Additionally, it is anticipated that demand for medical bionics and critical organ support systems will increase as a result of improved patient awareness and increased investment by major market players in developing economies, which is expected to fuel market growth throughout the forecast period for the market for these products.

Key Players

• The "Global Vital Organs Support Systems And Medical Bionics Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
• Abiomed Inc., Abbott Laboratories (St. Jude Medical), Baxter International Inc., Second Sight Medical Products Inc, Boston Scientific Corporation, Cochlear Ltd, Edwards Lifesciences Corporation, Jarvik Heart Inc, Asahi Kasei Corporation (Evaheart Medical U.S.A. Inc), Medtronic Plc (Covidien Ltd), Ossur Americas Inc, SynCardia Systems LLC, and others.
• Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.'

Key Developments

• In 2020, Sonova Group unveiled its EXCITE-Pro platform, which was demonstrated by HANSATON, a manufacturer and provider of hearing systems.
• Kindred Healthcare, LLC and Ekso Bionics Holdings, Inc. collaborated to pilot EksoNR, a robotic exoskeleton, in their long-term acute care hospitals in 2020.
• In 2020, the Cobalt & Crome portfolio of Cardiac Resynchronization Therapy-Defibrillators (CRT-D) and Implantable Cardioverter-Defibrillators (ICD) from Medtronic Plc. received the Conformite Europeenne (CE) mark.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories
• Active, Cutting Edge, Emerging, and Innovators.
• Market Attractiveness
• The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Vital Organs Support Systems And Medical Bionics market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the global Vital Organs Support Systems And Medical Bionics market, gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET

• 1.1 Market Definition
• 1.2 Market Segmentation
• 1.3 Research Timelines
• 1.4 Assumptions
• 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 2.1 Data Mining
• 2.2 Data Triangulation
• 2.3 Bottom-Up Approach
• 2.4 Top-Down Approach
• 2.5 Research Flow
• 2.6 Key Insights from Industry Experts
• 2.7 Data Sources

3 EXECUTIVE SUMMARY

• 3.1 Market Overview
• 3.2 Ecology Mapping
• 3.3 Absolute Market Opportunity
• 3.4 Market Attractiveness
• 3.5 Global Vital Organs Support Systems And Medical Bionics Market Geographical Analysis (CAGR %)
• 3.6 Global Vital Organs Support Systems And Medical Bionics Market, By Product (USD Million)
• 3.7 Global Vital Organs Support Systems And Medical Bionics Market, By End-User (USD Million)
• 3.8 Future Market Opportunities
• 3.9 Global Market Split
• 3.10 Product Life Line

4 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET OUTLOOK

• 4.1 Global Vital Organs Support Systems And Medical Bionics Evolution
• 4.2 Drivers
  • 4.2.1 Driver 1
  • 4.2.2 Driver 2
• 4.3 Restraints
  • 4.3.1 Restraint 1
  • 4.3.2 Restraint 2
• 4.4 Opportunities
  • 4.4.1 Opportunity 1
  • 4.4.2 Opportunity 2
• 4.5 Porters Five Force Model
• 4.6 Value Chain Analysis
• 4.7 Pricing Analysis
• 4.8 Macroeconomic Analysis

5 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Vital Organs Support Systems
  • 5.2.1 Artificial Heart
  • 5.2.2 Artificial Kidney
  • 5.2.3 Artificial Liver
  • 5.2.4 Others
• 5.3 Medical Bionics
  • 5.3.1 Cardiac Bionics
  • 5.3.2 Orthopedic Bionics
  • 5.3.3 Neural Bionics
  • 5.3.4 Others

6 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END-USER

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Ambulatory Surgical Centers
• 6.4 Others

7 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
  • 7.5.3 Rest of Latin America
• 7.6 Middle-East and Africa
  • 7.6.1 UAE
  • 7.6.2 Saudi Arabia
  • 7.6.3 South Africa
  • 7.6.4 Rest of Middle-East and Africa

8 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Developments
• 8.4 Company Regional Footprint
• 8.5 Company Industry Footprint
• 8.6 ACE Matrix

9 COMPANY PROFILES

• 9.1 Abiomed Inc
  • 9.1.1 Company Overview
  • 9.1.2 Company Insights
  • 9.1.3 Product Benchmarking
  • 9.1.4 Key Development
  • 9.1.5 Winning Imperatives
  • 9.1.6 Current Focus & Strategies
  • 9.1.7 Threat from Competition
  • 9.1.8 SWOT Analysis
• 9.2 Abbott Laboratories (St. Jude Medical)
  • 9.2.1 Company Overview
  • 9.2.2 Company Insights
  • 9.2.3 Product Benchmarking
  • 9.2.4 Key Development
  • 9.2.5 Winning Imperatives
  • 9.2.6 Current Focus & Strategies
  • 9.2.7 Threat from Competition
  • 9.2.8 SWOT Analysis
• 9.3 Asahi Kasei Corporation (Evaheart Medical U.S.A. Inc)
  • 9.3.1 Company Overview
  • 9.3.2 Company Insights
  • 9.3.3 Product Benchmarking
  • 9.3.4 Key Development
  • 9.3.5 Winning Imperatives
  • 9.3.6 Current Focus & Strategies
  • 9.3.7 Threat from Competition
  • 9.3.8 SWOT Analysis
• 9.4 Baxter International Inc
  • 9.4.1 Company Overview
  • 9.4.2 Company Insights
  • 9.4.3 Product Benchmarking
  • 9.4.4 Key Development
  • 9.4.5 Winning Imperatives
  • 9.4.6 Current Focus & Strategies
  • 9.4.7 Threat from Competition
  • 9.4.8 SWOT Analysis
• 9.5 Boston Scientific Corporation
  • 9.5.1 Company Overview
  • 9.5.2 Company Insights
  • 9.5.3 Product Benchmarking
  • 9.5.4 Key Development
  • 9.5.5 Winning Imperatives
  • 9.5.6 Current Focus & Strategies
  • 9.5.7 Threat from Competition
  • 9.5.8 SWOT Analysis
• 9.6 Cochlear Ltd
  • 9.6.1 Company Overview
  • 9.6.2 Company Insights
  • 9.6.3 Product Benchmarking
  • 9.6.4 Key Development
  • 9.6.5 Winning Imperatives
  • 9.6.6 Current Focus & Strategies
  • 9.6.7 Threat from Competition
  • 9.6.8 SWOT Analysis
• 9.7 Edwards Lifesciences Corporation
  • 9.7.1 Company Overview
  • 9.7.2 Company Insights
  • 9.7.3 Product Benchmarking
  • 9.7.4 Key Development
  • 9.7.5 Winning Imperatives
  • 9.7.6 Current Focus & Strategies
  • 9.7.7 Threat from Competition
  • 9.7.8 SWOT Analysis
• 9.8 Jarvik Heart Inc
  • 9.8.1 Company Overview
  • 9.8.2 Company Insights
  • 9.8.3 Product Benchmarking
  • 9.8.4 Key Development
  • 9.8.5 Winning Imperatives
  • 9.8.6 Current Focus & Strategies
  • 9.8.7 Threat from Competition
  • 9.8.8 SWOT Analysis
• 9.9 Medtronic Plc (Covidien Ltd)
  • 9.9.1 Company Overview
  • 9.9.2 Company Insights
  • 9.9.3 Product Benchmarking
  • 9.9.4 Key Development
  • 9.9.5 Winning Imperatives
  • 9.9.6 Current Focus & Strategies
  • 9.9.7 Threat from Competition
  • 9.9.8 SWOT Analysis
• 9.10 Ossur Americas Inc
  • 9.10.1 Company Overview
  • 9.10.2 Company Insights
  • 9.10.3 Product Benchmarking
  • 9.10.4 Key Development
  • 9.10.5 Winning Imperatives
  • 9.10.6 Current Focus & Strategies
  • 9.10.7 Threat from Competition
  • 9.10.8 SWOT Analysis
• 9.11 Second Sight Medical Products Inc
  • 9.11.1 Company Overview
  • 9.11.2 Company Insights
  • 9.11.3 Product Benchmarking
  • 9.11.4 Key Development
  • 9.11.5 Winning Imperatives
  • 9.11.6 Current Focus & Strategies
  • 9.11.7 Threat from Competition
  • 9.11.8 SWOT Analysis
• 9.12 SynCardia Systems LLC
  • 9.12.1 Company Overview
  • 9.12.2 Company Insights
  • 9.12.3 Product Benchmarking
  • 9.12.4 Key Development
  • 9.12.5 Winning Imperatives
  • 9.12.6 Current Focus & Strategies
  • 9.12.7 Threat from Competition
  • 9.12.8 SWOT Analysis

10 VERIFIED MARKET INTELLIGENCE

• 10.1 About Verified Market Intelligence
• 10.2 Dynamic Data Visualization